Beruflich Dokumente
Kultur Dokumente
Lesson No. CRCST 124 (Technical Continuing Education - TCE) by Susan Klacik, ACE, CHL, CRCST, FCS, CSS
Manager, St. Elizabeth Health Center
Sponsored by: Youngstown, Ohio
This series of self-study lessons on CSSD topics By mail or online: From January 1 to June 30 IAHCSMM provides online grading service for
was developed by the International Association of each year, Purdue Extended Campus offers an annual any of the Lesson Plan varieties. Purdue University
Healthcare Central Service Materiel Management mail-in or online, self-study lesson subscription for provides grading services solely for CRCST lessons.
(IAHCSMM). Purdue University’s Extended Campus $75 (6 specific lessons worth 2 points each). Call
and IAHCSMM both offer grading opportunities for 800.830.0629 for details. For grading of individual For more information:
Extended Campus points. lessons, send completed 20-question quiz and $15 Direct any questions about online grading to
to: PEC Business Office, Purdue University, Stewart IAHCSMM at 312.440.0078. Questions about writ-
Earn Extended Campus Points Center Room 110, 128 Memorial Mall, West Lafayette, ten grading are answered by Purdue University at
Online: You can use these lessons as an in-service IN 47907-2034. 800.830.0269. You can also print out any current
with your staff, or visit www.iahcsmm.org for online Each 20-question quiz with a passing score of valid lesson for grading at www.distance.purdue.edu/
grading at a nominal fee. 70% or higher is worth two points (contact hours) training/cssp/lessons/.
Each 20 question, online quiz with a passing score toward your CRCST re-certification (12 points). Two
of 70% or higher is worth two points (2 contact hours) attempts to achieve a passing score are permitted
toward your CRCST re-certification (12 points). per examination.
containing the above and any supplemen- FDA-regulated medi- reprocessing SUDs must comply with
tal information needed for the product’s FDA’s pre- and post-market requirements,
safe and effective use. The FDA-required cal devices include including a 510(k) approval for each type
labeling relies on broad disinfection of item. Use of a third party reprocessor is
terms based on the Spaulding classifica- the instrumentation, also acceptable (with 510(k) clearance).
tion system, which defines the following:
• Critical devices – Instruments or objects packaging, sterilizers, Objective 2: Review Occupa-
introduced directly into the human tional Safety and Health
body, (either into or in contact with the scopes, quality moni- Administration (OSHA) regula-
bloodstream or other normally sterile tions impacting Central Ster-
areas of the body), and products with tors, and implants ile Supply Departments.
sterile fluid pathways. The Occupational Safety and Health Ad-
• Semi-critical devices – Instruments or processed daily in ministration (OSHA) protects employees
objects that contact intact mucous by ensuring a safe work environment.
membranes or non-intact skin of the CSSDs; the level of Any substantiated or proven violation of
patient during use, but do not usually its regulations can yield fines and penal-
penetrate the blood barrier or other regulation and moni- ties for the employer. OSHA representa-
normally sterile areas of the body. tives visiting a facility for a specific reason
• Non-critical devices – Instruments toring depends upon have the right and obligation to investi-
or objects that usually contact only the gate any violation they find.
intact skin of the patient. the medical device OSHA has established occupational ex-
• Environmental surfaces – A variety of posure limits for several agents in chemi-
surfaces that usually do not come in classification. cal sterilants and disinfectants. Employers
contact with patients or, if they do, only must ensure compliance with these limits
with intact skin. by implementing engineering controls,
about patient deaths, serious injuries and defining procedures for safe employee
FDA’s policy requires that labeling not device malfunctions that could result in work practices, establishing medical sur-
contain references to specific diseases patient injury or death. They also require veillance programs, employing methods
or specific microorganisms, unless device user facilities (hospitals, nurs- for monitoring for occupational expo-
product lethality has been proven ing homes, ambulatory care facilities, sure, providing worker protection, and
effective by clinical trials. Users should and outpatient treatment and diagnostic taking other OSHA-specified measures.
be able to infer the microbiocidal efficacy facilities) to report to the FDA and device Product manufacturers might be sub-
of a product by examining its FDA- manufacturer deaths and serious injuries jected to certain labeling requirements.
cleared claims for use in sterilization or resulting in permanent disability. State and local health agencies also regu-
high-level disinfection. The FDA enacts product recalls and late certain aspects of chemical sterilant
FDA-regulated medical devices include monitors reports of adverse events or oth- use and disposal. These regulations must
the instrumentation, packaging, sterilizers, er problems with medical devices. This is be as stringent as federal requirements,
scopes, quality monitors, and implants done to alert health professionals and the and they are sometimes more stringent.
processed daily in CSSDs; the level of public, and ensure proper use of devices Healthcare personnel should know their
regulation and monitoring depends upon and the health and safety of patients. state and local obligations regarding stor-
the medical device classification. FDA’s Under the FDA medical device reporting age, use and disposal of these products.
system to determine the level of medical requirements, healthcare facilities must OSHA mandates that manufacturers
device regulation places each device into report suspected medical device-related provide material safety data sheets (MS-
one of three categories: Class I (low risk and deaths and injuries. The MedWatch DSs) for the chemicals they produce, and
least regulated), Class II (potential risk program is mandatory for death/perma- employers must make them available to
and moderate regulation), and Class III nent disability events and also encourages employees. The MSDSs provide informa-
(high risk and most stringent regulation). voluntary reporting of any device-related tion about:
Medical device reporting (MDR) problems or adverse events. • Identification
regulations require medical device manu- Reuse of single-use devices (SUDs) • Hazard(s) identification
facturers and importers to inform FDA are also regulated by the FDA. Hospitals • Ingredient composition
• First-aid measures CSSD professionals must be aware that plication, or any other conditions of use
• Fire-fighting measures the EPA also regulates ethylene oxide are not followed.
• Accidental release measures (EtO) under the Federal Insecticide,
• Handling and storage Fungicide, and Rodenticide Act. One Objective 4: Review require-
• Exposure controls/personal protection change, effective January 1, 2010, that ments of two other federal
• Physical and chemical properties affected CSSDs was the required phase- agencies that impact Central
• Stability and reactivity out of Oxyfume 2002. Oxyfume2000 , Sterile Supply Departments.
an alternate mixture of Oxyfume, can be The Department of Transportation
Toxicological, ecological, disposal, used until January 1, 2015, at which time (DOT) requires formal training of all
transport, regulatory, and other informa- it will also be phased-out (discontinued). persons who are involved in the shipping
tion is also provided on the MSDS. OSHA In 2008, the EPA completed a Rereg- process, including anyone who prepares
requires environmental monitoring of istration Eligibility Decision (RED) for hazardous items for shipment or pre-
Ethylene Oxide (EtO) and other chemi- EtO. It permits the continued use of EtO, pares shipping documents. Several levels
cals. It sets permissible exposure levels for provided users adopt new risk mitigation of training are specified, ranging from
these chemicals, and it specifies record measures indicated on EtO labels. Two “general awareness” to “function-specific.”
keeping, protective clothing, signage, first specific restrictions exist for healthcare The required training must include safety
aid, and other employee safety requirements. facility usage of EtO: issues and must be documented. If train-
Healthcare professionals, including • Sterilization/fumigation with EtO must ing records are not complete, the shipper
those in the CSSD, must also adhere to the be performed only in vacuum or gas tight is subject to significant penalties.
OSHA Bloodborne Pathogen Standard, chambers designed for use with EtO. The U.S. Centers for Disease Control
a comprehensive guideline for employee • After February 28, 2010, a single cham- and Prevention (CDC) promotes the
safety in all areas of a healthcare facil- ber process is required for EtO treatment health and quality of life by prevent-
ity. The Bloodborne Pathogen Standard (sterilization and aeration are to occur ing and controlling disease, injury and
mandates that employees working in the in the same chamber) in hospitals and disability, and by responding to health
decontamination room wear appropriate healthcare facilities.”1 emergencies. The CDC collaborates to
personal protective equipment to protect create the expertise, information and
against exposure to infectious materials. The EPA regulates disinfectants used tools required by people and communi-
on environmental (housekeeping and ties to protect their health. CDC per-
Objective 3: Discuss U.S. Envi- clinical contact) surfaces. Manufacturers sonnel accomplish this through health
ronmental Protection Agency must test formulations with accepted promotion, prevention of disease, injury,
(EPA) regulations of concern methods for microbicidal activity, and disability, and preparedness for new
to Central Sterile Supply stability and toxicity to animals and health threats. The CDC develops non-
Departments. humans, and these data must be submit- regulatory guidelines based on research
The EPA protects human health and the ted to EPA with proposed labeling. If and science.
environment. The agency’s goal is to EPA concludes a product does not cause
ensure that: unreasonable adverse effects, the product Objective 5: Demonstrate
• all Americans are protected from and its labeling receive an EPA registra- how voluntary standards
significant risks to human health and tion number. The manufacturer may then and recommended practices
the environment where they live, learn, sell and distribute the product in the influence work practices
and work; United States. in Central Sterile Supply
• national efforts to reduce environmental The following statement appears on all Departments.
risks are based on the best available EPA-registered product labels under the The following three voluntary organiza-
scientific information; and Directions for Use heading: “It is a viola- tions develop protocols that are used
• federal laws protecting human health tion of federal law to use this product by CSSDs:
and the environment are enforced fairly inconsistent with its labeling.” This means
and effectively. that users must follow the safety precau- The Joint Commission
The EPA implements environmental tions and use directions on the labeling The Joint Commission is an independent,
laws by developing regulations. Often, it of each registered product. The product not-for-profit organization that accredits
establishes national standards that states is considered to be misused if specified and certifies more than 19,000 healthcare
then enforce with their own regulations. dilutions, contact times, method of ap- organizations and programs in the United